| Multimodality MRI and Liquid Biopsy in GBM (NCT04776980) | Abramson Cancer Center at Penn Medicine | 2022-06-01 |
| Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients (NCT04988750) | NaviFUS Corporation | 2021-05-23 |
| Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) (NCT04427384) | GT Medical Technologies, Inc. | 2020-09-11 |
| Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6 (NCT04074785) | University of Texas Southwestern Medical Center | 2019-12-13 |
| Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors (NCT04023669) | St. Jude Children's Research Hospital | 2019-08-08 |
| Neurosurgical Transitional Care Programme (NCT03593330) | Barts & The London NHS Trust | 2019-05-30 |
| Vegetative Monitoring During Brainstem-associated Surgery (NCT03666507) | University Hospital Tuebingen | 2018-08-28 |
| Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors (NCT02905110) | The University of Texas Health Science Center, Houston | 2017-10-12 |
| Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma (NCT02940483) | The University of Texas Health Science Center, Houston | 2017-02-01 |
| T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors (NCT02442297) | Baylor College of Medicine | 2016-04-01 |
| Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors (NCT02644460) | Emory University | 2016-02-01 |
| More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery (NCT01445691) | Constantinos Hadjipanayis | 2015-11-01 |
| Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors (NCT02458339) | The University of Texas Health Science Center, Houston | 2015-06-15 |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas (NCT01966809) | Harry T Whelan, MD | 2015-06-01 |
| Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) (NCT03262636) | University of Pennsylvania | 2015-06-01 |
| D2C7 for Adult Patients With Recurrent Malignant Glioma (NCT02303678) | Darell Bigner | 2015-05-05 |
| Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas (NCT02238496) | Andrew B Lassman, MD | 2014-12-08 |
| ANG1005 in Patients With Recurrent High-Grade Glioma (NCT01967810) | Angiochem Inc | 2013-10-01 |
| Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. (NCT01520870) | Grupo Español de Investigación en Neurooncología | 2012-02-01 |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors (NCT00747253) | Monteris Medical | 2008-08-01 |
| Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma (NCT00575887) | Marmara University | 2006-08-01 |
| A Phase I/II Study of the Photon Radiosurgery System (NCT00179907) | Ann & Robert H Lurie Children's Hospital of Chicago | 2001-05-01 |
| Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers (NCT00141765) | University of Michigan Rogel Cancer Center | 1997-01-01 |